<DOC>
	<DOCNO>NCT01903434</DOCNO>
	<brief_summary>The purpose study measure compare amount study drug evacetrapib find blood take two different formulation . The study 3 period . Participants take formulation mouth least . A minimum 14 day pas study drug dos . The safety tolerability study drug also examine . Information side effect may occur also collect . This study last approximately 6 week .</brief_summary>
	<brief_title>A Study Evacetrapib ( LY2484595 ) Healthy Participants</brief_title>
	<detailed_description />
	<mesh_term>Evacetrapib</mesh_term>
	<criteria>Male participant agree use reliable method birth control donate sperm study 90 day study completion Female participant childbearing potential due surgical sterilization confirm medical history , menopause Have body mass index 18 32 kilogram per square meter ( kg/m^2 ) Are reliable willing make available duration study willing follow study procedure Are currently enrol , complete discontinue within last 30 day , clinical trial involve investigational product Have know allergy evacetrapib , related compound component formulation , history significant allergic disease determine investigator Have history presence cardiovascular , respiratory , hepatic , renal , gastrointestinal , endocrine , hematological , neurological disorder Regularly use know drug abuse and/or show positive finding urinary drug screening Are woman pregnant lactate Have use intend use overthecounter prescription medication ( include vitamins/mineral supplement , herbal medicine ) 14 day prior enrollment study Have donate blood 500 milliliter ( mL ) within last month Have average weekly alcohol intake exceed 21 unit per week ( male ) 14 unit per week ( female ) , unwilling stop alcohol consumption 48 hour prior dose resident Clinical Research Unit ( CRU ) Currently smoke use tobacco nicotine product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>